Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, ...
FinQuery, a market leader in AI-powered accounting automation, today announced the appointments of Jacob Fabbri as Chief Marketing Officer (CMO) and Michael Gerson as Senior Vice President of Customer ...
Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...
AT&T Inc. ( T) Q4 2025 Earnings Call January 28, 2026 8:30 AM EST Good morning, and welcome to AT&T's Fourth Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being ...
The Big Fix continues in line with Palazzo’s trend of presenting well-considered analysis regarding his adopted country’s ...
Dell's Alienware Area-51 laptop redefines high-performance computing, boasting an Intel Core Ultra 9 and RTX 5090 for ...
The Healthy @Reader's Digest on MSN
14 anti-aging breakthroughs dermatologists want you to know
Dermatologists share the anti-aging advances they love best for better skin health. The post 14 Anti-Aging Breakthroughs ...
Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Tucked between the vast Wyoming plains and the majestic Rocky Mountains, Rawlins offers something that feels increasingly like a fairy tale in today’s America: a place where you can actually afford to ...
The endothelial glycocalyx integrates mechanical signals with vascular biology, playing a vital role in health and disease, ...
New research shows how a cellular nanomachine controls protein delivery, helping explain how small failures disrupt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results